U
MTEM

UBS’s Molecular Templates, Inc. MTEM Stock Holding History

UBS’s Portfolio MTEM Stock Details MTEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$14K Buy
24
+8
+50% +$5.53K ﹤0.01% 8467
2014
Q2 		$11K Buy
16
+8
+100% +$5.3K ﹤0.01% 8808
2014
Q1 		$6K Sell
8
-11
-58% -$8.93K ﹤0.01% 9414
2013
Q4 		$14K Sell
19
-69
-78% -$52K ﹤0.01% 8614
2013
Q3 		$67K Buy
88
+57
+184% +$46.8K ﹤0.01% 6482
2013
Q2 		$27K Buy
+31
New +$26.2K ﹤0.01% 7522

Other funds holding MTEM

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

UBS's MTEM Position: Q3 2014 in Review

UBS increased its Molecular Templates, Inc. (MTEM) stake by 1,400% in Q3 2014, buying an estimated $349K and bringing the position to 540 shares worth $321K. The position accounts for ﹤0.01% of the portfolio, ranked #4708.

UBS first reported a position in MTEM in Q2 2013 and has held it in 6 quarters since. 92 funds tracked by Wall St. Rank hold MTEM as of Q3 2014.

  • UBS held 540 shares of Molecular Templates, Inc. worth $321K as of Q3 2014.
  • UBS bought 504 Molecular Templates, Inc. shares in Q3 2014, an estimated $349K.
  • Molecular Templates, Inc. made up ﹤0.01% of UBS's portfolio in Q3 2014, its #4708 holding.
  • UBS first reported a position in Molecular Templates, Inc. in Q2 2013 and has held it in 6 quarters since.
  • 92 funds tracked by Wall St. Rank held Molecular Templates, Inc. as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.